![]() Galectin Therapeutics Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer. | Khloris Biosciences Khloris Biosciences is a biotechnology company developing the treatment of cardiovascular, oncology, and other diseases. | Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | ||
Founding Date | Founding Date 2001 | Founding Date 2014 | Founding Date 2017 | Founding Date 2008 |
Type | Type Public | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Norcross, US HQ | Locations San Mateo, US HQ | Locations Mountain View, US HQ | |
Employees | Employees 717% increase | Employees 1122% increase | Employees 1214% decrease | Employees 5,669 |
Valuation ($) | Valuation ($) 155.1 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 8.8 b |
Financial | ||||
Net income | Net income ($30.8m) (FY, 2025) | Net income N/A | Net income N/A | Net income ¥67b (FY, 2025) |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 30m (over 5 years ago) | Latest funding round $ 5m (over 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 70m | Total funding raised $ 5m | Total funding raised N/A |

Vivace Therapeutics is a pharmaceutical company.
View companyKhloris Biosciences is a biotechnology company developing the treatment of cardiovascular, oncology, and other diseases.
View companyKyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company